| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,960 |
6,123 |
$432K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,274 |
4,728 |
$224K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,658 |
3,178 |
$137K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,831 |
1,649 |
$108K |
| 87428 |
|
1,580 |
1,293 |
$81K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,471 |
2,091 |
$63K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,805 |
3,350 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
444 |
379 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,168 |
914 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
538 |
423 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
444 |
379 |
$8K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
367 |
292 |
$5K |
| 81003 |
|
983 |
901 |
$1K |
| 99215 |
Prolong outpt/office vis |
16 |
13 |
$985.92 |
| 71046 |
Radiologic examination, chest; 2 views |
28 |
24 |
$428.57 |
| 90686 |
|
45 |
36 |
$371.47 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
86 |
70 |
$338.23 |
| 90674 |
|
18 |
18 |
$294.75 |
| 87807 |
|
29 |
27 |
$189.70 |
| 81025 |
|
30 |
28 |
$110.84 |
| 87081 |
|
26 |
18 |
$99.20 |
| H0033 |
Oral medication administration, direct observation |
47 |
45 |
$14.00 |
| A9150 |
Non-prescription drugs |
77 |
71 |
$10.48 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
70 |
55 |
$1.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
40 |
40 |
$0.11 |
| 99000 |
|
43 |
35 |
$0.03 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
15 |
12 |
$0.00 |